Literature DB >> 24157553

The concept of acute cerebrovascular syndrome.

Shinichiro Uchiyama1.   

Abstract

Early after the onset of transient ischemic attack (TIA), patients are at very high risk of stroke. There is no meaning to differentiate TIA in acute settings from acute ischemic stroke (AIS) only by the duration of symptoms. Acute TIA and AIS are on the same spectrum of acute ischemic syndrome in the central nervous system. We proposed a new concept termed acute cerebrovascular syndrome (ACVS), which includes TIA in acute settings and AIS. The concept of ACVS is comparable to acute coronary syndrome (ACS), which includes unstable angina and acute myocardial infarction. When a focal symptomatic reversible ischemia occurs in the brain, it is called TIA, and when a focal symptomatic irreversible ischemia occurs in the brain, it is called AIS. Patients with ACS share a single pathophysiological mechanism, that is rupture of unstable plaque followed by formation of platelet-rich thrombi to plug up coronary arteries. Unlike ACS, the mechanism of ACVS is complicated, which is not only large artery atherosclerosis similar to ACS but also cardioembolism or small vessel occlusion. In addition, there are no measurable biomarkers for ACVS, while there are practical biomarkers for ACS. Nevertheless, the concept of ACVS is practical to emphasize the importance of immediate evaluation and starting treatment to prevent subsequent stroke in acute settings of TIA. Therefore, TIA in acute settings as well as AIS should be recognized as ACVS, which is a medical emergency.
Copyright © 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2013        PMID: 24157553     DOI: 10.1159/000351888

Source DB:  PubMed          Journal:  Front Neurol Neurosci        ISSN: 0300-5186


  5 in total

Review 1.  An evidence-based update on the pharmacological activities and possible molecular targets of Lycium barbarum polysaccharides.

Authors:  Jiang Cheng; Zhi-Wei Zhou; Hui-Ping Sheng; Lan-Jie He; Xue-Wen Fan; Zhi-Xu He; Tao Sun; Xueji Zhang; Ruan Jin Zhao; Ling Gu; Chuanhai Cao; Shu-Feng Zhou
Journal:  Drug Des Devel Ther       Date:  2014-12-17       Impact factor: 4.162

2.  Thrombin induces ischemic LTP (iLTP): implications for synaptic plasticity in the acute phase of ischemic stroke.

Authors:  Efrat Shavit Stein; Zeev Itsekson-Hayosh; Anna Aronovich; Yair Reisner; Doron Bushi; Chaim G Pick; David Tanne; Joab Chapman; Andreas Vlachos; Nicola Maggio
Journal:  Sci Rep       Date:  2015-01-21       Impact factor: 4.379

3.  Prediction of Thromboembolic Events in Heart Failure Patients in Sinus Rhythm: The Hong Kong Heart Failure Registry.

Authors:  Jo-Jo Hai; Pak-Hei Chan; Yap-Hang Chan; Carol-Ho-Yi Fong; Duo Huang; Wen-Hua Li; Li-Xue Yin; Chu-Pak Lau; Hung-Fat Tse; Chung-Wah Siu
Journal:  PLoS One       Date:  2016-12-30       Impact factor: 3.240

Review 4.  Recent advances in the management of transient ischemic attacks.

Authors:  Camilo R Gomez; Michael J Schneck; Jose Biller
Journal:  F1000Res       Date:  2017-10-26

Review 5.  Recent advances in the management of transient ischemic attacks.

Authors:  Jorge Ortiz-Garcia; Camilo R Gomez; Michael J Schneck; José Biller
Journal:  Fac Rev       Date:  2022-07-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.